A double blind study of 2 mg versus 4 mg nicotine-gum in an industrial setting
- PMID: 3295212
- DOI: 10.1016/0022-3999(87)90073-0
A double blind study of 2 mg versus 4 mg nicotine-gum in an industrial setting
Abstract
In a double blind randomised trial to aid smoking cessation a 2 mg nicotine gum (n = 101) was compared with a 4 mg gum (n = 98), in smokers of at least 15 cigarettes/day. The trial involved blue and white collar workers and took place at their working place (industrial setting). Intervention during the one year follow-up period was minimal. At 3 months 36.2% of the 2 mg nicotine gum group reported to have stopped smoking, against 44.8% in the 4 mg group (non-significant difference). At one year in the 2 and 4 mg groups respectively 22.3 and 32.2% reported smoking abstinence (non significant difference). However in a sub-group with a higher nicotine-dependence score, only 18.5% were abstainers at one year in the 2 mg nicotine gum group against 32.9% in the 4 mg nicotine gum, which is a significant difference at the p = 0.05 level. This is however a post-hoc finding and should be taken with caution.
Similar articles
-
Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study.Clin Pharmacol Ther. 2005 Dec;78(6):689-96. doi: 10.1016/j.clpt.2005.08.019. Clin Pharmacol Ther. 2005. PMID: 16338284 Clinical Trial.
-
Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.Pediatrics. 2005 Apr;115(4):e407-14. doi: 10.1542/peds.2004-1894. Pediatrics. 2005. PMID: 15805342 Clinical Trial.
-
Effect of nicotine chewing gum in smoking cessation. A randomized, placebo-controlled, double-blind study.JAMA. 1984 Nov 23-30;252(20):2835-8. JAMA. 1984. PMID: 6387207 Clinical Trial.
-
Clinical use of nicotine chewing-gum.Br Med J. 1980 Jun 28;280(6231):1599-602. doi: 10.1136/bmj.280.6231.1599. Br Med J. 1980. PMID: 7000247 Free PMC article. Review.
-
Dependence potential and abuse liability of nicotine replacement therapies.Biomed Pharmacother. 1989;43(1):11-7. doi: 10.1016/0753-3322(89)90185-6. Biomed Pharmacother. 1989. PMID: 2659095 Review.
Cited by
-
Smokeless tobacco abstinence effects and nicotine gum dose.Psychopharmacology (Berl). 1992;106(1):60-6. doi: 10.1007/BF02253589. Psychopharmacology (Berl). 1992. PMID: 1738794 Clinical Trial.
-
Workplace interventions for smoking cessation.Cochrane Database Syst Rev. 2014 Feb 26;2014(2):CD003440. doi: 10.1002/14651858.CD003440.pub4. Cochrane Database Syst Rev. 2014. PMID: 24570145 Free PMC article.
-
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.Cochrane Database Syst Rev. 2023 Jun 19;6(6):CD013308. doi: 10.1002/14651858.CD013308.pub2. Cochrane Database Syst Rev. 2023. PMID: 37335995 Free PMC article.
-
Efficacy of bupropion alone and in combination with nicotine gum.Nicotine Tob Res. 2007 Sep;9(9):947-54. doi: 10.1080/14622200701540820. Nicotine Tob Res. 2007. PMID: 17763111 Free PMC article. Clinical Trial.
-
Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire.J Behav Med. 1989 Apr;12(2):159-82. doi: 10.1007/BF00846549. J Behav Med. 1989. PMID: 2668531 Review.